Severe Combined Immunodeficiency clinical trials
9 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
- Genetic Basis of Immunodeficiency
- Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- The Mechanistic Biology of Primary Immunodeficiency Disorders
- Evaluation of Patients With Immune Function Abnormalities
- An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID
- Natural History Study of SCID Disorders
- Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
- Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Severe Combined Immunodeficiency” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.